Iron Bisglycinate Safety, Side Effects and Contraindications

Iron bisglycinate is a popular mineral form of iron, often marketed as gentle on the stomach. That reputation is partly supported by research and partly overstated. This guide gives a balanced review of what human studies and safety reviews report about its side effects, serious risks, dose limits, contraindications and evidence gaps. It is written for information only and does not replace medical advice.

1. Safety Summary

Iron bisglycinate, also called ferrous bisglycinate chelate, is iron bound to two molecules of the amino acid glycine. It contains roughly 20 percent elemental iron by weight. In human trials, it is generally well tolerated, and the most common problems are digestive: nausea, stomach discomfort, constipation, diarrhea and dark stools. Several randomized trials and pooled analyses report fewer digestive complaints than with ferrous sulfate or ferrous fumarate, although the certainty of that evidence is limited.

The main serious risks of iron bisglycinate are the same as for any iron supplement. They are iron overload in people who absorb or store too much iron, accidental overdose in children, and interactions with some medicines. There is no strong evidence that the bisglycinate form carries unique toxicity, but there is also little long-term safety data specific to this form.

Medical disclaimer: This article does not diagnose, treat or prescribe. Whether iron bisglycinate is appropriate depends on blood tests, health conditions, medicines, pregnancy status and age. Speak with a doctor or pharmacist before starting any iron supplement, and keep all iron products out of reach of children.

What makes bisglycinate different is its structure. Because the iron is held in a chelate ring with glycine, it is thought to be less reactive in the stomach and less affected by dietary inhibitors such as phytates. Those properties may help explain its tolerability, but they do not remove the need for caution, because the iron is still absorbed and still counts toward total iron load.

At a glance: it is generally well tolerated at studied doses, side effects are mostly digestive and dose related, it is unsuitable for people with iron overload conditions, and anyone with a serious reaction or suspected overdose needs urgent medical care.

2. Common Reported Adverse Effects

Gastrointestinal complaints are by far the most commonly reported adverse effects in trials of oral iron. Unabsorbed iron irritates the lining of the gut and changes the intestinal environment, which explains why the symptoms appear even with well-absorbed forms. The table below summarizes the usual complaints.

Reported effect	How it is usually described	Practical notes from research
Nausea	Queasiness shortly after a dose, sometimes with vomiting	More frequent on an empty stomach and at higher doses.
Abdominal pain or cramping	Mild to moderate discomfort, bloating	A leading reason people stop taking iron in trials.
Constipation	Harder or less frequent stools	Common across all oral iron forms.
Diarrhea	Loose stools, less common than constipation	Reported in a smaller share of participants.
Dark or black stools	Greenish-black color	Expected and harmless in itself, but can hide or mimic bleeding.
Metallic taste or heartburn	Taste change, reflux-type discomfort	More common with liquid forms and higher doses.

 

A widely cited meta-analysis of ferrous sulfate trials found that digestive side effects were significantly more likely than with placebo, and that people taking ferrous sulfate were more likely to stop treatment. This is the background against which bisglycinate is compared.

In comparisons, iron bisglycinate has been linked to fewer digestive complaints. A randomized trial in pregnant women found that 25 mg of iron as bisglycinate prevented iron deficiency about as well as 50 mg of iron as ferrous fumarate, with fewer gastrointestinal symptoms. A systematic review of randomized trials also found fewer digestive adverse events with bisglycinate in some analyses.

Studies of dosing schedules point the same way. Research on ferrous salts shows that alternate-day or single morning doses can improve the share of iron absorbed, and trials that lower the dose or change the schedule often report fewer complaints. This suggests that tolerability is shaped by dose and timing as much as by the chemical form.

One caution is that many of these comparisons used a lower elemental iron dose for bisglycinate than for the comparison iron. Part of the benefit may therefore come from the lower dose rather than the chelate itself. Reported complaints are also usually self-rated, which makes them subjective.

3. Less Common and Serious Reports

Serious adverse events directly attributed to iron bisglycinate are rare in the published literature. Most randomized trials report only mild to moderate digestive problems, and few trials were designed to detect uncommon harms. The serious risks below are documented for oral iron generally and are relevant to bisglycinate as an iron source.

•        Iron poisoning: swallowing a large amount of iron can cause vomiting, bloody diarrhea, drowsiness, low blood pressure, metabolic acidosis and liver injury. This is a medical emergency, and iron supplements are a recognized cause of serious poisoning in young children.

•        Iron overload: long-term excess iron accumulates in the liver, heart, pancreas and joints. This is mainly a risk for people with genetic or acquired overload conditions, not for most people with normal iron regulation.

•        Gastrointestinal injury: tablets lodged in the throat or stomach can irritate the lining. Rare injuries and gut erosions are described with iron tablets in general.

•        Hypersensitivity reactions: severe allergic reactions are far more strongly associated with injected iron than oral iron, but reactions to oral products, often to additives, are possible.

•        Infection concerns: in malaria-endemic regions, a large trial of iron and folic acid in preschool children reported more severe illness in some children, which led to changes in public health guidance for those settings.

It is important to avoid overstating these findings. They are not specific to bisglycinate, and they mostly occur in particular conditions, high exposures or populations. Still, they explain why iron is treated more carefully than many other supplements.

4. Dose-Related Safety

Side effects of iron are dose related. Higher amounts of elemental iron leave more unabsorbed iron in the gut, and complaints rise accordingly. In addition, high doses raise hepcidin, the hormone that limits absorption, so large doses are not proportionally more effective.

The Tolerable Upper Intake Level (UL) for iron in adults is 45 mg per day, set mainly to avoid digestive side effects. The UL for children up to age 13 is 40 mg per day. The UL applies to total intake from supplements, fortified foods and diet, and it is not a recommended dose. Clinical trials in iron-deficient people sometimes exceed it under medical supervision.

Dose context (elemental iron)	Typical use in research	Safety observation
About 15 to 30 mg per day	Preventive use, pregnancy trials, tolerability studies of bisglycinate	Fewer digestive complaints reported, effective in several trials.
About 30 to 60 mg per day	Prevention and mild deficiency treatment	Digestive effects become more common, still within clinically studied ranges.
Above 60 mg per day	Deficiency treatment under supervision	More frequent side effects, absorption per dose falls.
Above the 45 mg UL	Clinical treatment only	Needs clinical supervision and monitoring of blood iron markers.
Toxic ingestion	Accidental or deliberate overdose	Medical emergency. Risk is weight based and highest in small children.

 

Always read the label carefully. Bisglycinate products may state the weight of the chelate, not the elemental iron. Since the chelate is around 20 percent iron, a capsule listing 100 mg of ferrous bisglycinate provides about 20 mg of iron. Confusing the two can lead to errors in either direction.

For poisoning, toxicity is generally described by body weight. Symptoms are usually associated with ingestion of roughly 20 mg of elemental iron per kilogram of body weight or more, and severe poisoning with much higher amounts. A small child can therefore reach a harmful amount from a handful of adult-strength tablets, which is why child-resistant packaging and secure storage matter.

Another dose-related issue is total intake. Many people take a multivitamin, a fortified cereal, an iron-containing protein supplement and a separate iron product at once. Adding all sources together is the only way to know whether intake is near or above the UL.

5. Duration of Use in Trials

Trials of iron bisglycinate are mostly short to medium in length. Typical studies run from 4 to 12 weeks, while pregnancy trials cover months, from the second trimester toward delivery or shortly afterward. Studies in children and infants commonly last about 2 to 3 months, and some fortification studies run longer.

Few trials go beyond 6 months, and very few follow participants for years. This means the available safety record mostly describes short-term use in people who were iron deficient or at risk of deficiency. It tells us little about continuous use for years, especially in people with normal iron status.

Clinical guidance for iron deficiency commonly describes treating until hemoglobin normalizes and then continuing for a period to rebuild stores, followed by reassessment with blood tests. The principle behind this is that iron is taken for a defined purpose and rechecked, not taken indefinitely.

6. Contraindications

A contraindication is a situation in which a treatment should generally not be used. For iron products, these are well established, and they apply to iron bisglycinate as a source of iron.

•        Hemochromatosis and other iron overload conditions: iron supplements are generally avoided because they can worsen accumulation. Hereditary hemochromatosis is relatively common in people of Northern European ancestry.

•        Anemia that is not caused by iron deficiency: examples include some thalassemias and anemias caused by chronic disease, where extra iron can add to overload without helping.

•        Repeated blood transfusions: transfusions already deliver large amounts of iron.

•        Known hypersensitivity to iron or to any ingredient in the product.

•        Certain digestive conditions: people with active inflammatory bowel disease, strictures, obstruction or a history of gut bleeding need medical guidance, because oral iron can aggravate symptoms.

Medicine interactions are also important. Iron can reduce absorption of other drugs, and some drugs reduce iron absorption. Common examples are listed below, and a pharmacist can advise on safe spacing.

•        Levothyroxine: iron can lower absorption of thyroid hormone, so these are usually separated by several hours.

•        Tetracycline and fluoroquinolone antibiotics: iron binds them and lowers their effect.

•        Bisphosphonates and some other bone medicines: absorption can be reduced by minerals.

•        Acid-reducing medicines such as proton pump inhibitors: they lower stomach acid and can reduce iron absorption.

•        Other minerals: calcium, zinc and magnesium can compete with iron when taken together.

7. Allergy Considerations

True allergy to iron itself is uncommon. Iron is an essential mineral present in every cell, and glycine, the amino acid in the chelate, is a normal building block of protein found in food. Neither is a typical allergen.

Allergic and intolerance reactions to iron bisglycinate products are more often linked to other ingredients. Capsules and tablets can contain soy derivatives, gluten-containing fillers, lactose, gelatin, artificial colors, flavors or preservatives. Liquid and gummy forms may contain sweeteners or flavorings that trigger reactions. Combination products may also include vitamin C, B vitamins or herbal extracts with their own allergen profiles.

Signs of allergy include hives, itching, swelling of the lips, face or throat, wheezing and breathing difficulty. Some people also experience stomach upset that is called an allergy but is actually intolerance. Anyone with known food allergies should read the full ingredient list and allergen statement, and if the label is unclear, ask the manufacturer or a pharmacist.

8. Organ-Specific Concerns Where Documented

Digestive system

This is where most documented effects occur. Symptoms are generally temporary and settle after dose reduction or stopping, though persistent symptoms should be reviewed by a clinician.

Liver

Liver injury is documented in acute iron overdose and chronic iron overload. It is not a typical finding in trials of bisglycinate at studied doses. People with existing liver disease should seek medical advice, because the liver stores and processes iron.

Heart and pancreas

Excess iron can damage heart muscle and the insulin-producing cells of the pancreas in iron overload disease. These effects arise from long-standing overload, not from short-term use of moderate doses in people with normal iron regulation.

Kidneys

Oral iron is commonly used in people with chronic kidney disease who have anemia, and no unique kidney toxicity of bisglycinate has been established. However, absorption can be impaired in this group, and treatment is directed by specialists.

Pregnancy and the fetus

Iron needs rise in pregnancy and supplementation is common. Some observational studies link very high hemoglobin during pregnancy with adverse outcomes, which suggests that routine supplementation without checking iron status may not be harmless. Pregnant women are advised to use iron under prenatal care.

Infants and children

The major concern is accidental overdose. In addition, a trial in Kenyan infants found that iron-containing fortification changed gut bacteria toward a less favorable profile and increased inflammation markers, raising questions about iron use in infants who are not deficient. Pediatric use should be guided by a clinician.

9. When to Stop and Seek Care

Mild digestive symptoms are common and may improve with a lower dose, a different schedule or guidance from a healthcare professional. Some signs require quicker action.

•        Seek emergency help immediately for swelling of the face or throat, trouble breathing, widespread hives or fainting.

•        Seek emergency help or contact a poison control center right away if a child or adult may have swallowed a large amount of iron, even if no symptoms are present yet. Symptoms can be delayed.

•        Seek urgent care for repeated vomiting, vomiting blood, severe abdominal pain, or black, sticky, tar-like stools with weakness or dizziness, since these can point to bleeding rather than harmless iron-related color change.

•        Contact a healthcare professional if constipation, nausea or pain is severe or lasts, if symptoms of overload such as joint pain, unusual fatigue or skin darkening develop, or if you become pregnant or start a new medicine.

Keep the product packaging and note the elemental iron content and the amount taken. This helps emergency staff and poison centers judge the risk quickly. Do not try to induce vomiting unless a medical professional tells you to.

Stopping a supplement on your own is reasonable when a reaction is serious. For ongoing treatment of a diagnosed deficiency, ask your clinician before changing the plan.

10. Safety Evidence Quality

The safety evidence for iron bisglycinate is moderate in volume but limited in quality and depth. It includes randomized trials in pregnant women, infants, children and adults, animal toxicology work from the 1990s, regulatory reviews that accept it as an iron source in supplements and foods, and systematic reviews of trials.

There are important limits. Many trials are small and short. Safety was often a secondary outcome rather than the main question, and adverse events are usually self-reported. Doses differ between bisglycinate and comparison arms, which makes fair comparison hard. Some studies were funded or supported by manufacturers, and the studied participants were mostly iron deficient or at risk, not the broader public. Pooled analyses often include trials of varying quality, which lowers confidence in the conclusions.

Quality also varies between products. Supplements are not tested for approval in the way medicines are in many countries, so actual iron content can differ from the label. Choosing products with third-party testing and clear elemental iron statements reduces this uncertainty, though it does not remove the underlying evidence gaps.

The absence of reports of serious harm should therefore be read carefully. It shows that serious problems are not common in studied settings, but it does not prove that they cannot occur, especially in uncommon conditions or with prolonged use.

11. Long-Term Safety Gaps

Several questions remain open for iron bisglycinate.

•        Years-long use: few studies follow continuous use beyond several months, so effects on iron stores over years are poorly described.

•        People with normal iron status: most research is in deficiency, leaving the effect of unneeded supplementation less clear. Studies suggest absorption from bisglycinate still responds to iron stores, but the relationship is not fully mapped.

•        Carriers of genetic variants affecting iron regulation: how supplements affect people with a single hemochromatosis gene variant or undiagnosed overload is not well studied.

•        Pregnancy: the ideal supplement choice and the effect of high hemoglobin on outcomes need more randomized evidence.

•        Infants and malaria regions: the balance of benefit and harm for chelated forms in these groups is uncertain.

•        Gut microbiome and inflammation: effects of chelated forms on gut bacteria compared with other iron forms are under-researched.

•        Combined sources: the cumulative effect of supplements, fortified foods and multiple products has rarely been tested.

Until these gaps are filled, the most defensible position is that iron bisglycinate appears well tolerated in short-term use for people who need iron, and that long-term or unsupervised use deserves caution.

12. FAQ

Is iron bisglycinate safe?

In studied doses and populations, it is generally well tolerated, with mostly mild digestive effects. Safety depends on a person's iron status, health conditions, medicines and dose, so it is not safe for everyone.

Does iron bisglycinate cause constipation?

It can. Constipation is a known effect of oral iron, though some trials report fewer digestive complaints with bisglycinate than with ferrous sulfate.

Is iron bisglycinate gentler than ferrous sulfate?

Some trials and pooled analyses suggest fewer digestive side effects. The evidence is not conclusive, partly because doses often differ between the compared products.

Can you overdose on iron bisglycinate?

Yes. Any iron product can cause poisoning if too much is taken, and children are especially vulnerable. Store it securely and seek emergency help after suspected overdose.

Who should avoid iron bisglycinate?

People with iron overload conditions such as hemochromatosis, those with anemias not caused by iron deficiency, and people with a known allergy to the product should avoid it unless a clinician advises otherwise.

Does iron bisglycinate interact with medicines?

It can, notably with levothyroxine, some antibiotics and bisphosphonates. A pharmacist can advise on timing.

Is it safe in pregnancy?

Iron is commonly used in pregnancy, and bisglycinate has been studied in pregnant women. Use should still be guided by prenatal care and blood test results.

How long is it safe to take?

Trials mostly last weeks to a few months. Long-term safety is less well documented, so continued use should be based on follow-up blood tests.

13. References

1.     Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academies Press; 2001.

2.     National Institutes of Health, Office of Dietary Supplements. Iron: Fact Sheet for Health Professionals.

3.     Milman N, et al. Ferrous bisglycinate 25 mg iron is as effective as ferrous fumarate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014;42(2):197-206.

4.     Fischer JAJ, et al. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023;81(8):904-920.

5.     Tolkien Z, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383.

6.     Jeppsen RB, Borzelleca JF. Safety evaluation of ferrous bisglycinate chelate. Food Chem Toxicol. 1999;37(7):723-731.

7.     Bovell-Benjamin AC, et al. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr. 2000;71(6):1563-1569.

8.     Sazawal S, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet. 2006;367:133-143.

9.     Jaeggi T, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731-742.

10.  Peña-Rosas JP, et al. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;CD004736.

11.  European Food Safety Authority. Scientific opinion on ferrous bisglycinate as a source of iron for use in foods and food supplements.

Editor note: confirm exact figures, authorship details and citations against the original sources before publishing.